The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lentiviral interferon with immune checkpoint blockade: A novel method for gene therapy in bladder cancer.
 
Sharada Mokkapati
No Relationships to Disclose
 
Andrea Kokorovic
No Relationships to Disclose
 
Jonathan J. Duplisea
No Relationships to Disclose
 
Devin Plote
No Relationships to Disclose
 
Amy Lim
No Relationships to Disclose
 
Vikram M. Narayan
No Relationships to Disclose
 
Michael J. Metcalfe
No Relationships to Disclose
 
Kenneth Dunner
No Relationships to Disclose
 
Bogdan Czerniak
No Relationships to Disclose
 
Tiina Nieminen
No Relationships to Disclose
 
Tommi Heikura
No Relationships to Disclose
 
Seppo Yla-Herttuala
No Relationships to Disclose
 
Nigel Parker
No Relationships to Disclose
 
David James McConkey
Stock and Other Ownership Interests - Apocell
 
Colin P.N. Dinney
Consulting or Advisory Role - FKD Therapies; Merck; NCI
Research Funding - FKD Therapies; Merck; NCI; University of Eastern Finland (Inst)